Mineralys Therapeutics Inc

MLYS NASDAQ Santé & Biotech États-Unis US6031701013
23.62 $
1.34 %

Mineralys Therapeutics se concentre sur le développement de thérapies pour des conditions cardiovasculaires telles que l'hypertension.

Performance & Momentum

6 Months 34.09 %
1 Year 52.80 %
3 Years 58.72 %
5 Years 28.85 %

Similar stocks to Mineralys Therapeutics Inc

Anantys Community

Be the first to share your analysis on Mineralys Therapeutics Inc.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases